Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial

BACKGROUND: Dual antiplatelet therapy (DAPT) with aspirin (ASP) and a P2Y(12) blocker is currently standard care after percutaneous coronary intervention (PCI) with stent insertion, and aims to inhibit platelet function in order to prevent stent thrombosis. The P2Y(12) blocker ticagrelor (TIC) has g...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Baos, Sarah, Underwood, Wendy, Culliford, Lucy, Reeves, Barnaby C., Rogers, Chris A., Bowles, Ruth, Johnson, Tom, Baumbach, Andreas, Mumford, Andrew
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5680755/
https://ncbi.nlm.nih.gov/pubmed/29121979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-2277-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky